Public production of anti-retroviral medicines in Brazil, 1990-2007

Development and Change

Volumn 39, Issue 4, 2008, Pages 513-536

  Flynn, Matthew ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIVIL SOCIETY; DRUG DEVELOPMENT; HEALTH SERVICES; HUMAN RIGHTS; MEDICINE; PHARMACEUTICAL INDUSTRY; PUBLIC HEALTH; STATE ROLE;

BRAZIL; SOUTH AMERICA;

EID: 53549090169     PISSN: 0012155X     EISSN: 14677660     Source Type: Journal    
DOI: 10.1111/j.1467-7660.2008.00494.x     Document Type: Article

References (58)

1. ALFOB (2006) 'Laboratorios'. Associação dos Laboratorios Farmacêuticas Oficiais do Brasil (Association of Official Laboratories of Brazil). http://www.alfob.org.br (accessed 6 May 2006).
2. Berkman, A., J. Garcia, M. Muñoz-Laboy, V. Paiva and R. Parker (2005) 'A Critical Analysis of the Brazilian Response to HIV/AIDS', American Journal of Public Health 95(7): 1162-72.
3. Bermudez, J. (1995) Industria Farmaceutica, Estado e Sociedade (Pharmaceutical Industry, State and Society). Sao Paulo: Hucitec/ Sobrevime.
4. Bermudez, J. and M.A. Oliveira (eds) (2004) Intellectual Property in the Context of the WTO Trips Agreement: Challenges to Public Health. Rio de Janeiro: ENSP.
5. Bermudez, J., M.A. Oliveira and E. Oliviera (2004) 'Expanding Access to Essential Medicines in Brazil', in J. Bermudez and M.A. Oliveira (eds) Intellectual Property in the Context of the WTO Trips Agreement: Challenges to Public Health, pp. 129-50. Rio de Janerio: ENSP.
6. Biehl, J. (2004) 'The Activist State: Global Pharmaceuticals, AIDS, and Citizenship in Brazil', Social Text 22(3): 105-32.
7. Boletín Farmacos (2005) 'Brazil, Abbott y Sida: Continúan Las Negociaciones' ('Brazil, Abbott and AIDS: The Negotiations Continue'), Boletín Farmacos (Drug Update) 8 (4). http://www.boletinfarmacos.org (accessed 8 May 2006).
8. Bresser-Pereira, L. (1999) 'Managerial Public Administration: Strategy and Structure for a New State', in L.B. Pereira and P. Spink (eds) Reforming the State: Managerial Public Administration in Latin America, pp. 1-14. Boulder, CO: Lynne Rienner.
9. Burity, J.A. (2006) 'Reform of the State and New Discourse on Social Policy in Brazil', Latin American Perspectives 33(148): 67-88.
10. Callegari, L. (2000) Análise Setorial: A Indústria Farmacêutica (Sectorial Analysis: The Pharmaceutical Industry). São Paulo: Gazeta Mercantil.
11. Cardoso, F. (2006) 'A sociedade como protagonista' ('Society as Protagonist'), in F. Cardoso A arte da política: A história que vivi (The Art of Politics: The History that I Lived). Rio de Janeiro: Civilização Brasileira.
12. Cassier, M. and M. Correa (2003) 'Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories' Experience in Copying AIDS Drugs', in J. P. Moatti et al. (eds) Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, pp. 89-103. Paris: Agence Nationale de Recherches sur le SIDA.
13. Cohen, J.C. and K.M. Lybecker (2005) 'AIDS Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health', The World Economy 28(2): 211-30.
14. Cosendey, M.A., J. Bermudez, A. Reis, H.F. Silva and M.A. Oliveira (2000) 'Assistência farmacêutica na atenção básica de saúde: A experiência de três estados brasileiros' ('Pharmaceutical Assistance in Basic Health Care: The Experience of Three Brazilian States'), Cadernos da Saúde Pública 16: 171-82.
15. Evans, P. (1996) 'Government Action, Social Capital and Development: Reviewing the Evidence on Synergy', World Development 24(6): 1119-32.
16. Far-Manguinhos (2007) 'Governo Brasileiro decreta licenciamento de medicamento contra Aids' ('Brazilian Government Decrees Compulsory Licence against AIDS'). http://www.far.fiocruz.br/cgi/cgilua.exe/sys/ start.htm?infoid=192&sid&=16 (accessed 8 May 2007).
17. Farmer, P. (2001) Infections and Inequalities: The Modern Plagues. Berkeley, CA: University of California Press.
18. Gauri, V. and E.S. Lieberman (2006) 'Boundary Institutions and HIV/AIDS Policy in Brazil and South Africa', Studies in International Comparative Development 41(4): 47-73.
19. Gomez, E. (2006) 'The Politics of Government Response to HIV/AIDS in Russia and Brazil: Historical Institutionalism, Culture and State Capacity'. Working Paper 4, Harvard Initiative for Global Health. Cambridge, MA: Harvard University.
20. Grangeiro, A., L. Teixeira, F.I. Bastos and P. Teixeira (2006) 'Sustainability of Brazilian Policy for Access to Antiretroviral Drugs', Revista Saúde Púbica 40: 1-9.
21. Grupemef/Febrafarma (2007) 'Mercado Farmacêutico: Brasil' ('Pharmaceutical Market: Brazil'). http://www.febrafarma.org.br/ divisoes.php?area=ec&secao=vd&modulo=arqs_economia (accessed 2 April 2008).
22. Guimier, J.-M., E. Lee and M. Grupper (2004) Processes and Issues for Improving Access to Medicines. London: DFID Health Systems Resource Centre.
23. Hass, N. (2003) 'Brazil Receives Accolades for Comprehensive AIDS Program'. Policy Update, August. New York: Sexuality Information and Education Council of the United States.
24. Hickey, S. and G. Mohan (2005) 'Relocating Participation within a Radical Politics of Development', Development and Change 36(2): 237-62.
25. Homedes, N. and A. Ugalde (2006) 'Improving Access to Pharmaceuticals: The Cases of Brazil and Argentina', Health Policy and Planning 21(2): 123-31.
26. Huber, E. (1995) 'Options for Social Policy in Latin America: Neo-Liberal versus Social Democratic Models', in G. Esping-Anderson (ed.) Welfare States in Transition, pp. 141-91. London: Sage Publications.
27. Kaplan, W. and R. Laing (2005) Local Production: Industrial Policy and Access to Medicines. Washington, DC: The World Bank.
28. Kingstone, P. (1999) Crafting Coalitions for Reform: Business Preferences, Political Institutions, and Neoliberal Reform in Brazil. University Park, PA: Pennsylvania State University Press.
29. Mattos, R., V. Terto and R. Parker (2003) 'World Bank Strategies and the Response to AIDS in Brazil', Divulgação em Saúde para Debate 27: 215-27.
30. Ministry of Health (2000) 'A Dor dos Remédios' ('The Pain of Remedies'). Brasília: Ministry of Health.
31. Ministry of Health (2002) 'Far-Manguinhos: Remédio para o Brasil' ('Far-Manguinhos: A Remedy for Brazil'). Rio de Janeiro: Ministry of Health/FioCruz.
32. Ministry of Health (2003) 'Acesso aos Medicamentos, Compras Governamentais e Inclusão Social' ('Access to Medicines, Government Purchases and Social Inclusion'). http://www2.desenvolvimento.gov.br/arquivo/sdp/proacao/ forcompetitividade/notastecnicas/anexo_2.pdf (accessed 20 July 2005).
33. Ministry of Health (2005a) 'The Sustainability of Universal Access to Antiretroviral Medicines in Brazil'. National STD/AIDS Programme. http://www.aids.gov.br/data/documents/storedDocuments/%7BB8EF5DAF- 23AE-4891-AD36-1903553A3174%7D/%7B6AB55CB8-AD0A-42C7-BE9C- 1E86CFE66F40%7D/Cons._nacional_sustainability.doc (accessed 22 September 2005).
34. Ministry of Health (2005b) 'Vitória brasileira contra a Aids' ('Brazilian Victory Against AIDS'). http://portal.saude.gov.br/portal/ aplicacoes/noticias/noticias_detalhe.cfm?co_seq_noticia=21026 (accessed 21 November 2006).
35. Ministry of Health (2006) 'Policy of the National Programme'. National STD/AIDS Programme. http://www.aids.gov.br/data/Pages/ LUMIS7A1D4F9DITEMIDB4089BC29CA3440BAF51C69212882EDDENIE.htm (accessed 21 November 2006).
36. Ministry of Health (2008a) 'Custo dos Medicamentos AIDS'. Department of Pharmaceutical Assistance and Strategic Inputs. Brasilia: Ministry of Health.
37. Ministry of Health (2008b) 'Programa Mais Saúde: Direito de todos 2008-2011' ('More Health Programme: The Right of Everyone 2008-2011'). http://bvsms.saude.gov.br/bvs/pacsaude/programa.php (accessed 15 March 2008)
38. Ministry of Health (2008c) 'UNGASS: Resposta Brasileira 2005-2007 Relatório de Progresso do País' ('UNGASS: Brazilian Response 2005-2007 Report on Country's Progress'). http://portal.saude.gov.br/portal/arquivos/pdf/ relatorio_ungass_2008_pt.pdf (accessed 15 February 2008).
39. Ministry of Health/FioCruz (2005) 'Relatório de Gestão 2004' ('Management Report 2004'). Rio de Janeiro: FioCruz. http://www.fiocruz.br/media/rel_ges_2004.pdf (accessed 22 June 2006).
40. Nunn, A., E. Fonseca, F. Bastos, S. Gruskin and J. Salomon (2007) 'Evolution of Antiretroviral Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment', PLOS Med 4(11): 1804-17.
41. Oliveira, E., M. Labra and J. Bermudez (2006) 'A produção pública de medicamentos no Brasil: Uma visão geral' ('The Public Production of Medicines in Brazil: A General Vision'), Cadernos da Saúde Pública 22(11): 2379-89.
42. Orsi, F., L. Hasenclever, B. Fialho, P. Tigre and B. Coriat (2003) 'Intellectual Property Rights, Anti-AIDS Policy and Generic Drugs', in J.P. Moatti et al. (eds) Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, pp. 109-35. Paris: Agence Nationale pour Recherche sur le Sida.
43. Palmeiro, P. and S. Pan (2003) 'Cadeia Farmacêutica No Brasil: Avaliação Preliminar e Perspectivas' ('Pharmaceutical Chain in Brazil: Preliminary Evaluation and Perspectives'), BNDES Setorial 18: 3-22 (September).
44. Parker, R. (2003) 'Building the Foundations for the Response to HIV/AIDS in Brazil: The Development of HIV/AIDS Policy, 1982-1996', Divulgação em Saúde para Debate 27: 143-83.
45. Passarelli, C.A. and V. Terto (2003) 'Non-Governmental Organizations and Access to Anti-retroviral Treatments in Brazil', Divulgação em Saúde pare Debate 27: 252-64.
46. Petras, J. and H. Veltmeyer (2003) Cardoso's Brazil: A Land for Sale. Lanham, MD: Rowman & Littlefield.
47. Rabi, J. (2007) 'Políticas Públicas e o Empreendedorismo Em Química No Brasil: O Caso da Microbiológica' ('Public Policies and Entrepreneurship in Chemistry in Brazil: The Case of Microbiologica'), Química Nova 30(6): 1420-28.
48. Skidmore, T. (1999) Brazil: Five Centuries of Change. New York: Oxford University Press.
49. Tarchinardi, M.H. (1993) A Guerra das Patentes (The Patent War). Rio de Janeiro: Editora Paz e Terra.
50. Teixeira, P., M.A. Vitória and J. Barcarolo (2003) 'The Brazilian Experience in Providing Universal Access to Antiretroviral Therapy', in J.P. Moatti et al. (eds) Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, pp. 69-86. Paris: Agence Nationale pour Recherche sur le Sida.
51. UNAIDS (2006) The Road towards Universal Access: Scaling Up Access to HIV Prevention, Treatment, Care and Support. Geneva: UNAIDS.
52. United Nations (2000) 'The Right to the Highest Attainable Standard of Health Care'. CESCR General Comment No 14. Geneva: The United Nations Economic and Social Council.
53. United Nations (2001) 'Declaration of Commitment on HIV/AIDS'. New York: United Nations.
54. Weyland, K. (1995) 'Social Movements and the State: The Politics of Health Reform in Brazil', World Development 23(10): 1699-1712.
55. Weyland, K. (2002) The Politics of Market Reform in Fragile Democracies: Argentina, Brazil, Peru, and Venezuela. Princeton, NJ: Princeton University Press.
56. WHO (2004) 'Manufacture of Antiretrovirals in Developing Countries and Challenges for the Future'. Geneva: World Health Organization.
57. WHO (2006) 'Progress on Global Access to HIV Antiretroviral Therapy: A Report on "3 by 5" and Beyond'. Geneva: World Health Organization.
58. World Bank (1997) Confronting AIDS: Public Priorities in a Global Epidemic. Washington, DC: The World Bank.